Details for New Drug Application (NDA): 212204
✉ Email this page to a colleague
The generic ingredient in BORTEZOMIB is bortezomib. There are twenty drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the bortezomib profile page.
Summary for 212204
Tradename: | BORTEZOMIB |
Applicant: | Hetero Labs Ltd Vi |
Ingredient: | bortezomib |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 212204
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | Strength | 3.5MG/VIAL | ||||
Approval Date: | May 3, 2024 | TE: | AP | RLD: | No |
Complete Access Available with Subscription